|Novadaq Technologies Inc -- USA Stock|| |
USD 11.75 0.00 0.00%
Co-Founder, Sr. VP and General Manager
Dr. Rick Mangat, Ph.D., is President, Chief Executive Officer of Novadaq Technologies Inc. Dr. Mangat cofounded Novadaq in April of 2000 and is a coinventor of the SPY System. The research element of his PhD thesis performed at the National Research Council of Canada formed the foundation for SPY Imaging and related IP. Dr. Mangat has led the research, development and commercialization teams at Novadaq from benchtop through clinical use of the SPY System, and is now responsible for the general management of Novadaqs commercial business unit including Sales and Marketing
Founder Since 2016 Ph.D
Mangat received his BS from the University of Toronto and a PhD from the University of Manitoba.
The company has return on total asset (ROA)
of (26.33) %
which means that it has lost $26.33 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (48.87) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 9.59 M in liabilities with Debt to Equity (D/E) ratio of 10.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Novadaq Technologies Inc has Current Ratio of 3.42 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging solutions for use by surgeons in the operating room and other clinical settings in the United States and internationally. Novadaq Technologies Inc (NVDQ) is traded on NASDAQ General Markets in USA. It is located in ONTARIO, CANADA and employs 215 people. Novadaq Technologies is listed under Medical Equipment category by Fama And French industry classification.